| # | Drug | Count |
|---|---|---|
| 0 | RIBAVIRIN | 11 |
| 1 | FLUOROURACIL | 7 |
| 2 | FLUOROURACIL CREAM, 0.5% | 7 |
| 3 | BEVACIZUMAB | 5 |
| 4 | METHOTREXATE | 5 |
| 5 | METHOTREXATE SODIUM | 5 |
| 6 | DEXAMETHASONE | 4 |
| 7 | DEXAMETHASONE 1.5 MG | 4 |
| 8 | MYCOPHENOLATE MOFETIL | 4 |
| 9 | PREDNISOLONE | 4 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | CANGRELOR | 1 | 0.0025 |
| 1 | CHLOROQUINE PHOSPHATE | 1 | 0.0015 |
| 2 | OLEZARSEN SODIUM | 1 | 0.0011 |
| 3 | CHOLESTERINUM | 1 | 0.0009 |
| 4 | DICHLORPHENAMIDE | 1 | 0.0006 |
| 5 | TRANDOLAPRIL TABLETS | 1 | 0.0005 |
| 6 | AMIVANTAMAB-VMJW | 1 | 0.0003 |
| 7 | IRINOTECAN HYDROCHLORIDE | 3 | 0.0002 |
| 8 | PANITUMUMAB | 3 | 0.0002 |
| 9 | RIBAVIRIN | 11 | 0.0002 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Nucleoside Analog Antiviral [EPC] | 11 | 0.0001 |
| 1 | Dopamine-2 Receptor Antagonist [EPC] | 1 | 0.0001 |
| 2 | Potassium-sparing Diuretic [EPC] | 1 | 0.0001 |
| 3 | Epidermal Growth Factor Receptor Antagonist [EPC] | 3 | 0.0001 |
| 4 | Peroxisome Proliferator Receptor alpha Agonist [EPC] | 3 | 0.0001 |
| 5 | CD52-directed Cytolytic Antibody [EPC] | 1 | 0.0001 |
| 6 | Carbonic Anhydrase Inhibitor [EPC] | 1 | 0.0000 |
| 7 | Antimetabolite Immunosuppressant [EPC] | 1 | 0.0000 |
| 8 | Poly(ADP-Ribose) Polymerase Inhibitor [EPC] | 1 | 0.0000 |
| 9 | Androgen [EPC] | 1 | 0.0000 |